TY  - JOUR
AU  - Dodi, Giuseppe
AU  - Jongen, Johannes
AU  - de la Portilla, Fernando
AU  - Raval, Manoj
AU  - Altomare, Donato F
AU  - Lehur, Paul-Antoine
PY  - 2010
DO  - 10.1155/2010/467136
SN  - 1687-6121
UR  - http://hdl.handle.net/10668/2068
T2  - Gastroenterology research and practice
AB  - Fecal incontinence (FI) is the involuntary loss of rectal contents through the anal canal. Reports of its prevalence vary from 1-21%. Studies, have demonstrated a positive effect on FI symptoms with injectable bulking agents. This study evaluated the...
LA  - en
PB  - Hindawi Publishing Corporation
KW  - Incontinencia fecal
KW  - Canal Anal
KW  - Dextranos
KW  - Humanos
KW  - Inyecciones
KW  - Calidad de vida
KW  - Prevalencia
KW  - Medical Subject Headings::Diseases::Digestive System Diseases::Gastrointestinal Diseases::Intestinal Diseases::Rectal Diseases::Fecal Incontinence
KW  - Medical Subject Headings::Anatomy::Digestive System::Gastrointestinal Tract::Intestines::Intestine, Large::Anal Canal
KW  - Medical Subject Headings::Chemicals and Drugs::Macromolecular Substances::Polymers::Biopolymers::Glucans::Dextrans
KW  - Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Administration Routes::Injections
KW  - Medical Subject Headings::Disciplines and Occupations::Social Sciences::Quality of Life
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Morbidity::Prevalence
TI  - An Open-Label, Noncomparative, Multicenter Study to Evaluate Efficacy and Safety of NASHA/Dx Gel as a Bulking Agent for the Treatment of Fecal Incontinence
TY  - research article
ER  -